‘Holy Grail’ Sleep Apnea Pill Can Cut Episodes by More Than 50%

A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a sleep apnea drug called AD109. After various clinical trials, they are preparing to file for FDA approval. “A pill for sleep apnea has always been the holy grail,” Dr. Andrew Wellman, a Harvard sleep researcher, told Forbes, noting that over the past several years, at least 40 drug candidates have been tested for obstructive sleep apnea (OSA) without success.